ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
NewLimit
NewLimit is seeking a Scientist with expertise in liver biology and metabolism to join its Metabolism team, focusing on developing reprogramming medicines to restore youthful function in aged hepatocytes. The role involves collaborating with cross-functional teams to design and test epigenetic reprogramming interventions for liver disease models. The scientist will develop functional assays, evaluate therapeutic candidates, and deliver perturbations in vivo to support pre-clinical decision-making.
Headquarters
South San Francisco, California, United States
Company Size
11-50 employees
Founded
2022
NewLimit is a biotechnology company focused on extending human healthspan by unlocking regenerative potential. It builds therapies and platform technologies aimed at restoring youthful function to tissues and organs by targeting core cellular and molecular drivers of aging. NewLimit advances programs through preclinical research and collaborations to translate regenerative biology into treatments for age‑related disease. The company emphasizes translational science with the goal of delivering durable, clinically meaningful rejuvenation across organ systems.
Endpoints NewsAnti-aging biotech NewLimit brings in Eli Lilly as investor, raising $45M
Oct 20, 2025
Fierce BiotechAnti-aging biotech NewLimit raises $130M to push liver reprogramming med into clinic
May 6, 2025
Longevity.TechnologyNewLimit ‘close’ to clinic-ready epigenetic reprogramming therapy
Nov 27, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for NewLimit.
NewLimit Raises $45 Million Funding to Advance Longevity Research
Oct 21, 2025
Senior Staff Scientist – iPSC-Derived Liver Cell Engineering
Terasaki Institute for Biomedical Innovation
Research Associate II/ Senior Research Associate, Therapeutics
Arbor Biotechnologies
Contractor, Drug Metabolism and Pharmacokinetics (DMPK)
PTC Therapeutics
Scientist I, Cell and Molecular Biology, Gene Editing
Editas Medicine
Research Associate / Senior Research Associate, Translational Pharmacology
Ratio Therapeutics
Advisor – In Vivo CAR Discovery
Eli Lilly and Company
